Scientia Advisors to Moderate Business Expert Panel on Molecular Diagnostics at Molecular Medicine Tri-Conference

Cambridge, MA, November 24, 2008 --(PR.com)-- Scientia Advisors’ Managing Partner, Harry Glorikian, will moderate a discussion by business experts on Global Trends in Molecular Diagnostics at the 16th International Molecular Medicine Tri-Conference on Friday, February 27th, 2009. The panel will consist of the former CEO and President of Roche Diagnostics, Tiffany Olson, the Vice President of Molecular Diagnostics at Perkin Elmer, Howard Grey, and Director of Business Development at Bio-Rad Laboratories, Todd Morrill.

The conference will run from February 25-27, 2009 at the Moscone North Convention Center in San Francisco, California. For more information, please visit: www.tri-conference.com/09_mdx.asp

Harry Glorikian heads Scientia Advisors based on 20 years of experience in the health care and life science industries. He is known worldwide as a leader in helping companies streamline their operations and accelerate their growth. Having held senior management positions at Applied Bio Systems, Signet Laboratories, in Massachusetts, and at X-Cell Laboratories, Inc., in California, Harry has deep commercial background in diagnostics, molecular biology, proteomics, cellular biology and biodefense. His unique understanding of technologies, operations and strategy from both buyer and internal company perspectives has shaped Scientia's sophisticated framework and proprietary analytic tools. He writes for industry media, is frequently quoted in periodicals, and is a sought-after speaker who advises media and industry leaders on current trends in life science, health care and business. Harry also serves on many advisory boards.

###